FGXI Names Charles Hinkaty Director

 

Smithfield, RI (September 28th, 2008)

 

On September 18th, 2008, the Board of Directors for FGX International (NASDAQ: FGXI) appointed Charles Hinkaty as a director of the Company for a term ending at the 2009 Annual Meeting of Stockholders.  Previously, Mr. Hinkaty was the President and Chief Executive Officer of Del Laboratories, Inc. from August 2005 through his retirement in January 2008.  Previously, Mr. Hinkaty was the Chief Operating Officer of Del Laboratories, Inc. from January 2005 until August 2005, and President and Vice President of Del Pharmaceuticals, Inc. since 1985.  Mr. Hinkaty served as a director of Del Laboratories, Inc. until December 2007. 

Mr. Hinkaty has been appointed to the Audit Committee, the Compensation Committee and the Nominating and Corporate Governance Committee of the Board of Directors effective September 18, 2008.

FGX International is a leading designer and marketer of non-prescription reading glasses, sunglasses and costume jewelry with a portfolio of established, well-recognized brands including Foster Grant, Magnivision, Anarchy, Angel and Gargoyles.  FGXI also holds licenses from Ironman, Levi Strauss, Field & Stream, Body Glove and C9 by Champion. Based in Smithfield, Rhode Island, FGXI has approximately 300 full-time employees.  Additional offices are located in New York, Toronto, Stoke-on-Trent, England, Mexico City, Bentonville, AR and Shenzhen, China.

For additional information contact: 

Sal Siano
Phone:  (401) 719-2160
E-mail:  ssiano@fgxi.com